Comparing the outcome of doublet therapy (gemcitabine and cisplatin) with triplet therapy (gemcitabine, cisplatin and nab paclitaxel) in locally advanced or metastatic gall bladder carcinoma patients: An open-label randomized control trial.
Journal of Clinical Oncology, Volume 40, Issue 4_suppl, Page TPS497-TPS497, February 2022.